|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02563 BIOSTAR PHARM-B
Nominal 
29.050 0.000 (0.000%) | 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | |
| Turnover | 66,635 | 103.032% | 32,820 |
| Cost of Sales | (19,810) | 121.588% | (8,940) |
| Gross Profit | 46,825 | 96.085% | 23,880 |
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | |
| Profit / (Loss) before Taxation | (189,644) | 18.150% | (160,511) | |
| Taxation | 0 | -- | 0 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | |
| Non-controlling Interests | 0 | -- | 0 | |
| Others | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (189,644) | 18.150% | (160,511) | |
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | |
| Net Finance Costs / (Income) | (13,081) | 300.031% | (3,270) |
| Depreciation & Amortisation | 10,622 | 1.143% | 10,502 |
| Directors' Emoluments | 35,092 | -41.215% | 59,696 |
| 2023/12 - Final | %Chg (Compare to Final) | 2022/12 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified |
Market Valuation Indicators
| 2023/12 - Final | %Chg (Compare to Final) | 2022/12 | |
| EPS (cts) | -54.000 | 17.391% | -46.000 |
| DPS (cts) | -- | -- | -- |
| Dividend Payout Ratio (%) | -- | -- | -- |
| Cash flow per share ($) | (0.427) | -- | (0.227) |
| NBV per share ($) | -- | -- | -- |
| Remarks: | Real time quote last updated: 22/11/2024 07:50 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB -189,644,000 |
| %Change | 18.150% |
| EPS / (LPS) | RMB -0.540 |
| NBV Per Share (¥) | RMB -- |